1. Kang, W.-J., et al., Analysis on distribution, drug resistance and risk factors of multi drug resistant bacteria in diabetic foot infection. Biomedical Research, 2018. 28(22): p. 10186-10190. 2. Velissaris, D., et al., Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review. Romanian Journal of Internal Medicine, 2018. 56(1): p. 3-8. 3. Apelqvist, J., The Diabetic Foot Syndrome Today: A Pandemic Uprise, in The Diabetic Foot Syndrome. 2018, Karger Publishers. p. 1-18. 4. Aragón-Sánchez, J., The Role of Surgery in the Management of the Infected Diabetic Foot, in The Diabetic Foot Syndrome. 2018, Karger Publishers. p. 184-199. 5. Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A (2000) Cost burden to diabetic patients with foot complications- a study from southern India. J Assoc Physicians India 48: 1147–1150. 6. Adler AI, Boyko EJ, Ahroni JH, Smith DG (1999) Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 22: 1029–1035. 7. Urbancic-Rovan V, Gubina M (1997) Infections in diabetic patients: The role of anaerobes. Clin Infect Dis 25: S184–185. 8. E. M. Shankar, V. Mohan, G. Premalatha, R. S. Srinivasan, and A. R. Usha, “Bacterial etiology of diabetic foot infections in South India,” European Journal of Internal Medicine, vol. 16, no. 8, pp. 567–570, 2005. 9. H. Galkowska, A. Podbielska, W. L. Olszewski et al., “Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers,” Diabetes Research and Clinical Practice, vol. 84, no. 2, pp. 187–193, 2009. 10. N. Parvez, P. Dutta, P. Ray et al., “Microbial profile and utility of soft tissue, pus, and bone cultures in diagnosing diabetic foot infections,” Diabetes Technology & Therapeutics, vol. 14, no. 8, pp. 669–674, 2012. 11. Sugandhi and D. A. Prasanth, “Microbiological profile of bacterial pathogens from diabetic foot infections in tertiary care hospitals, Salem,” Diabetes & Metabolic Syndrome, vol. 8, no. 3, pp. 129–131, 2014. . 12. Xie, X., et al., Bacterial Profile and Antibiotic Resistance in Patients with Diabetic Foot Ulcer in Guangzhou, Southern China: Focus on the Differences among Different Wagner’s Grades, IDSA/IWGDF Grades, and Ulcer Types. International journal of endocrinology, 2017. 2017. 13. Motta RN, Oliveira MM, Magalhaes PS, Dias AM, Aragao LP, Forti AC, et al. Plasmid-mediated extended-spectrum betalactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center. Braz J Infect Dis. 2003;7:129-34. 14. Louie TJ, Bartlett JG, Tally FP, Gorbach SL. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med. 1976; 85:461-3. 15. Djahmi, N., et al., Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clinical Microbiology and Infection, 2013. 19(9). 16. Shahi, S.K., V.K. Singh, and A. Kumar, Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam. PloS one, 2013. 8(7): p. e68234. 17. El-Badawy, M.F., et al., Iodometric and molecular detection of ESBL production among clinical isolates of E. coli fingerprinted by ERIC-PCR: the first Egyptian report declares the emergence of E. coli O25b-ST131clone harboring bla GES. Microbial Drug Resistance, 2017. 23(6): p. 703-717. 18. Jain, A., et al., Prevalence of extended-spectrum β-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. Journal of Medical Microbiology, 2003. 52(5): p. 421-425. 19. Varaiya, A.Y., et al., Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infections. Indian Journal of Pathology and Microbiology, 2008. 51(3): p. 370. 20. Heidari-soureshjani, E., M. Heidari, and A. Doosti, Epidemiology of urinary tract infection and antibiotic resistance pattern of E. coli in patients referred to Imam Ali hospital in Farokhshahr, Chaharmahal va Bakhtiari, Iran. Journal of Shahrekord Uuniversity of Medical Sciences, 2013. 15(2): p. 9-15. 21. Molazade, a., et al., Evaluation of Antibiotic Resistance Pattern of Isolated Gram-Negative Bacteria from Urine Culture of Hospitalized patients in Different Wards of Vali-Asr Hospital in Fasa During the Years 2012 and 2013. Journal of Fasa University of Medical Sciences, 2014. 4(3): p. 275-283. 22. Hamid-Farahani, R., et al., Antibiotic resistance pattern of E.coli isolated from urine culture in 660 Army clinical laboratory center in Tehran 2008. Ann Mil Health Sci Res, 2012. 10(1): p. 45-49. 23. Rava, M., Trend of antibiotic resistance of Escherichia coli strains isolated from urinary tract infections in outpatient patients from Zahedan. Journal of Paramedical Sciences & Rehabilitation, 2017. 6(4): p. 73-78. 24. Mathai D, Rhomberg PR, Bledenbach DJ, Jones RN (2002) Evaluation of the in vitro activity of six broad-spectrums beta-lactam antimicrobial agents against recent clinical isolates from India; A survey of ten medical center laboratories. Diagn Microbiol Infect Dis 44: 367–377. 25. Mansouri, M. and R. Ramazanzadeh, Spread of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates in Sanandaj Hospitals. Journal of biological sciences, 2009. 9(4): p. 362-366. 26. haghighat panah, m., et al., Surveying of antibiotic resistance pattern and frequency rate of blaTEM in the ESBLs producing E. coli isolated in Rasht. journal of ilam university of medical sciences, 2014. 22(4): p. 180-189.